MGC Diagnostics (MGCD) Posts Surprise Q3 Loss

MGC Diagnostics (NASDAQ: MGCD) reported Q3 EPS of ($0.21), $0.29 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $6.6 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Green Dot and CommerceOne shareholders approve acquisition deal